$EMED
Electromedical Technologies, Inc

2021 Q3 Form 10-Q Financial Statement

#000141057821000301 Filed on November 15, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3 2020 Q2
Revenue $301.2K $205.9K $136.8K
YoY Change 46.3% -23.98%
Cost Of Revenue $66.73K $57.38K $18.00K
YoY Change 16.29% -60.99%
Gross Profit $234.4K $148.5K $118.8K
YoY Change 57.9% -11.21%
Gross Profit Margin 77.84% 72.12% 86.84%
Selling, General & Admin $455.0K $2.243M $936.7K
YoY Change -79.72% 203.42%
% of Gross Profit 194.09% 1511.03% 788.71%
Research & Development $0.00 $4.000K
YoY Change -81.02%
% of Gross Profit 0.0% 3.37%
Depreciation & Amortization $5.468K $5.468K $5.469K
YoY Change 0.0% -59.55%
% of Gross Profit 2.33% 3.68% 4.61%
Operating Expenses $455.0K $2.243M $936.7K
YoY Change -79.72% 184.04%
Operating Profit -$220.6K -$2.095M -$817.9K
YoY Change -89.47% 317.28%
Interest Expense $1.105M $52.66K $14.56K
YoY Change 1998.58% -225.75%
% of Operating Profit
Other Income/Expense, Net -$3.079M -$75.07K -$22.35K
YoY Change 4001.65% 61.58%
Pretax Income -$3.300M -$2.170M -$840.3K
YoY Change 52.07% 279.49%
Income Tax
% Of Pretax Income
Net Earnings -$3.300M -$2.170M -$840.3K
YoY Change 52.07% 279.48%
Net Earnings / Revenue -1095.71% -1054.16% -614.42%
Basic Earnings Per Share -$0.06
Diluted Earnings Per Share -$60.71K -$99.20K -$40.90K
COMMON SHARES
Basic Shares Outstanding 54.36M
Diluted Shares Outstanding 54.36M

Balance Sheet

Concept 2021 Q3 2020 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $164.8K $85.48K $127.1K
YoY Change 92.81%
Cash & Equivalents $164.8K $85.48K $127.1K
Short-Term Investments
Other Short-Term Assets $23.94K $209.8K $68.62K
YoY Change -88.59% -33.55%
Inventory $229.9K $62.50K $39.97K
Prepaid Expenses
Receivables $30.93K $16.84K $18.69K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $449.6K $374.6K $254.4K
YoY Change 20.01% 15.15%
LONG-TERM ASSETS
Property, Plant & Equipment $732.8K $754.7K $760.2K
YoY Change -2.9% -2.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $13.60K $85.60K $65.86K
YoY Change -84.11%
Total Long-Term Assets $746.4K $840.3K $826.0K
YoY Change -11.17% -9.1%
TOTAL ASSETS
Total Short-Term Assets $449.6K $374.6K $254.4K
Total Long-Term Assets $746.4K $840.3K $826.0K
Total Assets $1.196M $1.215M $1.080M
YoY Change -1.56% -4.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $244.3K $330.7K $361.2K
YoY Change -26.14% 46.68%
Accrued Expenses $195.8K $254.0K $266.8K
YoY Change -22.94% 55.19%
Deferred Revenue $2.267K
YoY Change
Short-Term Debt $0.00 $39.50K $39.50K
YoY Change -100.0%
Long-Term Debt Due $1.075M $488.7K $1.940M
YoY Change 120.01% 11.99%
Total Short-Term Liabilities $2.336M $1.372M $2.723M
YoY Change 70.22% 17.75%
LONG-TERM LIABILITIES
Long-Term Debt $680.9K $708.2K $715.7K
YoY Change -3.85% -34.19%
Other Long-Term Liabilities $10.16K $18.79K $21.96K
YoY Change -45.92% -2.92%
Total Long-Term Liabilities $10.16K $727.0K $737.6K
YoY Change -98.6% -33.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.336M $1.372M $2.723M
Total Long-Term Liabilities $10.16K $727.0K $737.6K
Total Liabilities $3.027M $2.099M $3.461M
YoY Change 44.19% 1.11%
SHAREHOLDERS EQUITY
Retained Earnings -$20.02M
YoY Change
Common Stock $747.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.831M -$884.2K -$2.381M
YoY Change
Total Liabilities & Shareholders Equity $1.196M $1.215M $1.080M
YoY Change -1.56% -4.35%

Cashflow Statement

Concept 2021 Q3 2020 Q3 2020 Q2
OPERATING ACTIVITIES
Net Income -$3.300M -$2.170M -$840.3K
YoY Change 52.07% 279.48%
Depreciation, Depletion And Amortization $5.468K $5.468K $5.469K
YoY Change 0.0% -59.55%
Cash From Operating Activities -$177.6K -$549.7K -$246.6K
YoY Change -67.7% -6.41%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.818M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -38.07K 508.1K 334.8K
YoY Change -107.49% 27.06%
NET CHANGE
Cash From Operating Activities -177.6K -549.7K -246.6K
Cash From Investing Activities
Cash From Financing Activities -38.07K 508.1K 334.8K
Net Change In Cash -215.6K -41.60K 88.20K
YoY Change 418.34%
FREE CASH FLOW
Cash From Operating Activities -$177.6K -$549.7K -$246.6K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
110400
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Registrant Name
EntityRegistrantName
Electromedical Technologies, Inc
dei Entity Central Index Key
EntityCentralIndexKey
0001715819
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Amendment Flag
AmendmentFlag
false
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2267
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56192
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-2619815
dei Entity Address Address Line1
EntityAddressAddressLine1
16561 N. 92nd Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Ste. 101
dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85260
dei City Area Code
CityAreaCode
888
dei Local Phone Number
LocalPhoneNumber
880-7888
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
164810
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
264913
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
30931
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17694
CY2021Q3 us-gaap Inventory Net
InventoryNet
229906
CY2020Q4 us-gaap Inventory Net
InventoryNet
78712
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23936
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
285860
CY2021Q3 us-gaap Assets Current
AssetsCurrent
449583
CY2020Q4 us-gaap Assets Current
AssetsCurrent
647179
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13601
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
20601
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
732813
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
749219
CY2021Q3 us-gaap Assets
Assets
1195997
CY2020Q4 us-gaap Assets
Assets
1416999
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
244264
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
262614
CY2021Q3 elcq Credit Cards Payable
CreditCardsPayable
14769
CY2020Q4 elcq Credit Cards Payable
CreditCardsPayable
23710
CY2021Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
195755
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
201814
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2267
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
28651
CY2020Q4 elcq Discount On Convertible Promissory Notes Current
DiscountOnConvertiblePromissoryNotesCurrent
159114
CY2021Q3 elcq Discount On Convertible Promissory Notes Current
DiscountOnConvertiblePromissoryNotesCurrent
1277255
CY2021Q3 elcq Convertible Promissory Notes Payable Current
ConvertiblePromissoryNotesPayableCurrent
813239
CY2020Q4 elcq Convertible Promissory Notes Payable Current
ConvertiblePromissoryNotesPayableCurrent
257398
CY2021Q3 elcq Related Party Notes Payable Current
RelatedPartyNotesPayableCurrent
233500
CY2020Q4 elcq Related Party Notes Payable Current
RelatedPartyNotesPayableCurrent
332500
CY2020Q4 elcq Payroll Protection Program Loan
PayrollProtectionProgramLoan
39500
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
12846
CY2021Q3 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
28516
CY2020Q4 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
28260
CY2021Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
803219
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
831852
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2335529
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2019145
CY2021Q3 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
525851
CY2020Q4 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
546552
CY2021Q3 us-gaap Other Loans Payable Long Term
OtherLoansPayableLongTerm
155063
CY2020Q4 us-gaap Other Loans Payable Long Term
OtherLoansPayableLongTerm
154302
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10162
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15603
CY2021Q3 us-gaap Liabilities
Liabilities
3026605
CY2020Q4 us-gaap Liabilities
Liabilities
2735602
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
500000
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
500000
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
355000
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
355000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74926711
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27175800
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
747
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
269
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17828794
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7957860
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20015149
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9631732
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-1830608
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1318603
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1195997
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1416999
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
301157
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
205850
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
670551
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
557476
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
66733
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
57383
us-gaap Cost Of Revenue
CostOfRevenue
158065
us-gaap Cost Of Revenue
CostOfRevenue
139892
CY2021Q3 us-gaap Gross Profit
GrossProfit
234424
CY2020Q3 us-gaap Gross Profit
GrossProfit
148467
us-gaap Gross Profit
GrossProfit
512486
us-gaap Gross Profit
GrossProfit
417584
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
454997
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2243377
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2822251
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3768196
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-220573
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2094910
us-gaap Operating Income Loss
OperatingIncomeLoss
-2309765
us-gaap Operating Income Loss
OperatingIncomeLoss
-3350612
CY2021Q3 us-gaap Interest Expense
InterestExpense
1105069
CY2020Q3 us-gaap Interest Expense
InterestExpense
52658
us-gaap Interest Expense
InterestExpense
2937851
us-gaap Interest Expense
InterestExpense
82168
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
-7784
CY2021Q3 elcq Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
1974164
CY2020Q3 elcq Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
22415
elcq Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
1436756
elcq Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
22415
elcq Other Nonoperating Income Expenses
OtherNonoperatingIncomeExpenses
-432
elcq Other Nonoperating Income Expenses
OtherNonoperatingIncomeExpenses
1500
elcq Debt Instrument Forgiveness Of Debt
DebtInstrumentForgivenessOfDebt
-50082
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3079233
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-75073
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4324957
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-110867
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3299806
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2169983
us-gaap Net Income Loss
NetIncomeLoss
-6634722
us-gaap Net Income Loss
NetIncomeLoss
-3461479
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
54356854
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21875068
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39670934
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20201697
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1318603
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
693826
CY2021Q1 elcq Adjustments To Additional Paid In Capital Warrants Issued In Conjunction With Convertible Promissory Notes
AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithConvertiblePromissoryNotes
420096
CY2021Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
380103
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
604901
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2560384
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1780061
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
974314
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11350
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-774532
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1469879
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2939077
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3299806
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-1830608
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-2184437
CY2020Q1 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
7352
CY2020Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
290000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5265
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-451241
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-2333061
CY2020Q2 elcq Stock Issued During Period Value In Conjunction With Convertible Promissory Notes
StockIssuedDuringPeriodValueInConjunctionWithConvertiblePromissoryNotes
42969
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
8800
CY2020Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
600000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
37149
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000
CY2020Q2 elcq Value Of Warrants Issued In Conjunction With Convertible Promissory Notes
ValueOfWarrantsIssuedInConjunctionWithConvertiblePromissoryNotes
48231
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5481
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-840255
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-2380686
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
390000
CY2020Q3 elcq Stock Issued During Period Value Conversion Of Convertible Securities Related Party
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesRelatedParty
1452545
CY2020Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1818000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5953
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2169983
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-884171
us-gaap Net Income Loss
NetIncomeLoss
-6634722
us-gaap Net Income Loss
NetIncomeLoss
-3461479
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3495
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3765
us-gaap Share Based Compensation
ShareBasedCompensation
1409127
us-gaap Share Based Compensation
ShareBasedCompensation
2761848
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16406
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16406
elcq Forgiveness Of Debt Instrument
ForgivenessOfDebtInstrument
49783
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
-7784
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2785844
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
33038
elcq Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
1436756
elcq Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
22415
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-2839
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16732
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4939
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
151194
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
37806
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-261924
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
128960
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-7000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
60021
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
57036
elcq Increase Decrease In Credit Card Payables
IncreaseDecreaseInCreditCardPayables
-8941
elcq Increase Decrease In Credit Card Payables
IncreaseDecreaseInCreditCardPayables
-8478
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
75083
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
7488
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-906073
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-28401
elcq Increase Decrease In Customer Deposits Operating Activities
IncreaseDecreaseInCustomerDepositsOperatingActivities
-26384
elcq Increase Decrease In Customer Deposits Operating Activities
IncreaseDecreaseInCustomerDepositsOperatingActivities
24660
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-5441
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-795644
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-40308
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
39500
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
155900
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
19684
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
12471
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-99000
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
24500
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
937500
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
665000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
12846
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
805970
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
881121
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-100103
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
85477
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
264913
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
164810
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
85477
us-gaap Interest Paid Net
InterestPaidNet
29625
us-gaap Interest Paid Net
InterestPaidNet
37408
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
7352
elcq Warrants Common Stock And Beneficial Conversion Feature Issued In Conjunction With Convertible Promissory Note
WarrantsCommonStockAndBeneficialConversionFeatureIssuedInConjunctionWithConvertiblePromissoryNote
420096
elcq Warrants Common Stock And Beneficial Conversion Feature Issued In Conjunction With Convertible Promissory Note
WarrantsCommonStockAndBeneficialConversionFeatureIssuedInConjunctionWithConvertiblePromissoryNote
490000
elcq Derivative Liabilities Issued In Conjunction With Convertible Promissory Notes
DerivativeLiabilitiesIssuedInConjunctionWithConvertiblePromissoryNotes
1197607
elcq Derivative Liabilities Issued In Conjunction With Convertible Promissory Notes
DerivativeLiabilitiesIssuedInConjunctionWithConvertiblePromissoryNotes
171892
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
4290655
elcq Conversion Of Kiss Liability Related Party To Common Stock
ConversionOfKissLiabilityRelatedPartyToCommonStock
1452545
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration:underline;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of certain assets and liabilities, certain disclosures at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Significant estimates affecting the financial statements have been prepared on the basis of the most current and best available information. However, actual results from the resolution of such estimates and assumptions may vary from those used in the preparation of the financial statements.</p>
elcq Accumulated Net Loss
AccumulatedNetLoss
15800000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-906073
elcq Working Capital Deficit
WorkingCapitalDeficit
1885946
elcq Sales Returns Allowance
SalesReturnsAllowance
11485
CY2020 elcq Sales Returns Allowance
SalesReturnsAllowance
6990
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2267
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
28651
elcq Initial Warranty Period
InitialWarrantyPeriod
P3Y
CY2021Q3 us-gaap Deferred Income
DeferredIncome
29281
CY2020Q4 us-gaap Deferred Income
DeferredIncome
35200
CY2021Q3 us-gaap Receivables From Customers
ReceivablesFromCustomers
15328
CY2020Q4 us-gaap Receivables From Customers
ReceivablesFromCustomers
13800
CY2021Q3 us-gaap Due From Customer Acceptances
DueFromCustomerAcceptances
12800
CY2020Q4 us-gaap Due From Customer Acceptances
DueFromCustomerAcceptances
0
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
28651
CY2021Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
803219
CY2020Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
831852
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
831852
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
1436756
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
1197607
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
-2662996
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
803219
CY2021Q3 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
61000
CY2020Q4 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
58000
elcq Standard Warranty Period
StandardWarrantyPeriod
P3Y
CY2021Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
14936
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
17483
elcq Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Outstanding Warrants Stock Options And Convertible Promissory Notes
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfOutstandingWarrantsStockOptionsAndConvertiblePromissoryNotes
13800000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
732813
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
749219
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5468
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5468
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16406
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
899987
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
899987
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
167174
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
150768
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16406
CY2021Q3 elcq Interest Income Expense Related Party Net
InterestIncomeExpenseRelatedPartyNet
7561
CY2020Q3 elcq Interest Income Expense Related Party Net
InterestIncomeExpenseRelatedPartyNet
0
elcq Interest Income Expense Related Party Net
InterestIncomeExpenseRelatedPartyNet
14182
elcq Interest Income Expense Related Party Net
InterestIncomeExpenseRelatedPartyNet
0
CY2021Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
972353
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1534653
CY2021Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
159114
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1277255
CY2021Q3 us-gaap Notes Payable
NotesPayable
813239
CY2020Q4 us-gaap Notes Payable
NotesPayable
257398
CY2021Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
972353
CY2021Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
159114
CY2021Q3 us-gaap Notes Payable
NotesPayable
813239
CY2020Q4 elcq Warrants Issued
WarrantsIssued
135000
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.50
CY2020Q4 elcq Fair Value Of Warrant
FairValueOfWarrant
190144
CY2021Q1 elcq Warrants Issued
WarrantsIssued
2500000
CY2021Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.40
CY2021Q1 elcq Fair Value Of Warrant
FairValueOfWarrant
420096
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.025
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.025
CY2021Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1058643
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2785844
CY2021Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
159114
CY2021Q3 elcq Additional Interest Expense
AdditionalInterestExpense
30063
CY2020Q3 elcq Additional Interest Expense
AdditionalInterestExpense
10790
elcq Additional Interest Expense
AdditionalInterestExpense
110635
elcq Additional Interest Expense
AdditionalInterestExpense
12047
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
831852
elcq Derivative Liabilities Conversion Of Promissory Notes
DerivativeLiabilitiesConversionOfPromissoryNotes
-2662996
elcq Derivative Liabilities In Conjunction With Promissory Notes
DerivativeLiabilitiesInConjunctionWithPromissoryNotes
1197607
elcq Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
1436756
CY2021Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
803219
CY2021Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1084120
CY2021Q1 elcq Stock Issued During Period Value Conversion Of Convertible Note And Notes Payable
StockIssuedDuringPeriodValueConversionOfConvertibleNoteAndNotesPayable
693837
CY2021Q1 elcq Stock Issued During Period Value Per Share Issued For Services
StockIssuedDuringPeriodValuePerShareIssuedForServices
0.64
CY2021Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
50000
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
8400
CY2021Q2 elcq Stock Issued During Period Value Per Share Issued For Services
StockIssuedDuringPeriodValuePerShareIssuedForServices
0.168
CY2021Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1200000
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
102000
CY2021Q2 elcq Stock Issued During Period Value Per Share Issued For Services
StockIssuedDuringPeriodValuePerShareIssuedForServices
0.085
CY2020Q2 elcq Stock Issued During Period Shares Conversion Of Convertible Note And Notes Payable
StockIssuedDuringPeriodSharesConversionOfConvertibleNoteAndNotesPayable
1000000
elcq Stock Issued During Period Value Conversion Of Convertible Note And Notes Payable
StockIssuedDuringPeriodValueConversionOfConvertibleNoteAndNotesPayable
1549800
elcq Stock Issued During Period Shares Conversion Of Convertible Note And Notes Payable
StockIssuedDuringPeriodSharesConversionOfConvertibleNoteAndNotesPayable
43316791
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
10000000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5481
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10946
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
445000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.71
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y6M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
445000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.71
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y9M
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
420000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.71
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P0Y9M
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
445000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.71
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P0Y9M
CY2021Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2500000
CY2021Q1 elcq Warrants Issued
WarrantsIssued
2500000
CY2021Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.40
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.025
CY2021Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
420096
CY2020Q2 elcq Stock Issued During Period Shares Conversion Of Convertible Note And Notes Payable
StockIssuedDuringPeriodSharesConversionOfConvertibleNoteAndNotesPayable
1000000
CY2021Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10800000

Files In Submission

Name View Source Status
0001410578-21-000301-index-headers.html Edgar Link pending
0001410578-21-000301-index.html Edgar Link pending
0001410578-21-000301.txt Edgar Link pending
0001410578-21-000301-xbrl.zip Edgar Link pending
elcq-20210930.xsd Edgar Link pending
elcq-20210930x10q.htm Edgar Link pending
elcq-20210930x10q001.jpg Edgar Link pending
elcq-20210930x10q_htm.xml Edgar Link completed
elcq-20210930xex10d59.htm Edgar Link pending
elcq-20210930xex10d59002.jpg Edgar Link pending
elcq-20210930xex10d60.htm Edgar Link pending
elcq-20210930xex10d61.htm Edgar Link pending
elcq-20210930xex31d1.htm Edgar Link pending
elcq-20210930xex31d2.htm Edgar Link pending
elcq-20210930xex32d1.htm Edgar Link pending
elcq-20210930xex32d2.htm Edgar Link pending
elcq-20210930_cal.xml Edgar Link unprocessable
elcq-20210930_def.xml Edgar Link unprocessable
elcq-20210930_lab.xml Edgar Link unprocessable
elcq-20210930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending